IMORX | PEMGX | IMORX / PEMGX | |
Total Expense Ratio | 1.44 | 0.91 | 158% |
Annual Report Gross Expense Ratio | 1.44 | 0.91 | 158% |
Fund Existence | 14 years | 20 years | - |
Gain YTD | 6.934 | 1.713 | 405% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 706M | 31.8B | 2% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | -1.54 | -3.50 | 44% |
Returns for 3 years | 33.31 | 47.85 | 70% |
Returns for 5 years | -25.61 | 34.38 | -75% |
Returns for 10 years | -20.77 | 98.22 | -21% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CSHI | 49.84 | 0.06 | +0.12% |
NEOS Enhanced Inc 1-3 Month T-Bill ETF | |||
LFAL | 137.04 | N/A | N/A |
Stone Ridge 2053 Longevity Income ETF | |||
OVB | 20.78 | -0.01 | -0.02% |
Overlay Shares Core Bond ETF | |||
SDG | 83.67 | -0.05 | -0.06% |
iShares MSCI Global Sust Dev Goals ETF | |||
IWN | 176.53 | -0.30 | -0.17% |
iShares Russell 2000 Value ETF |